[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@doctorvasan Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::169325323.png) @doctorvasan Red-pilled Rebel

Red-pilled Rebel posts on X about $35b, $nams, $353b, $13byr the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::169325323/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::169325323/c:line/m:interactions.svg)

- X Week XXXXX +0.86%
- X Month XXXXX +161%
- X Months XXXXXX +80%
- X Year XXXXXX +32%

### Mentions: X [#](/creator/twitter::169325323/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::169325323/c:line/m:posts_active.svg)

- X Week XX +17%
- X Month XX +6.90%
- X Months XXX +96%
- X Year XXX -XXXX%

### Followers: XXXXX [#](/creator/twitter::169325323/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::169325323/c:line/m:followers.svg)

- X Week XXXXX -XXXX%
- X Month XXXXX +0.61%
- X Months XXXXX +5.70%
- X Year XXXXX -XXXX%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::169325323/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::169325323/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::169325323/influence)
---

**Social category influence**
[currencies](/list/currencies)  XXXX% [stocks](/list/stocks)  XXXX%

**Social topic influence**
[$35b](/topic/$35b) #19, [$nams](/topic/$nams) 9.09%, [$353b](/topic/$353b) 9.09%, [$13byr](/topic/$13byr) 9.09%, [events](/topic/events) 9.09%, [combo](/topic/combo) 9.09%, [has been](/topic/has-been) 9.09%, [$14b](/topic/$14b) 9.09%, [$5b](/topic/$5b) 9.09%, [$1b](/topic/$1b) XXXX%

**Top accounts mentioned or mentioned by**
[@jpegan10](/creator/undefined) [@adityarajkaul](/creator/undefined) [@lkatheeq](/creator/undefined) [@dkshivakumar](/creator/undefined) [@mlanaharis](/creator/undefined) [@captainmani72](/creator/undefined) [@bcbengaluru](/creator/undefined)

**Top assets mentioned**
[NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS)](/topic/$nams)
### Top Social Posts [#](/creator/twitter::169325323/posts)
---
Top posts by engagements in the last XX hours

"Obicetrapib =Statin XXX Ever wondered why statins became a $35B+ global juggernaut in 2009 Blockbuster LDL-C lowering met exploding awareness of heart disease risks. Now enter obicetrapib $NAMS poised to eclipse that trajectory in a smarter hungrier market. 🧵"  
[X Link](https://x.com/doctorvasan/status/1981713278377058364) [@doctorvasan](/creator/x/doctorvasan) 2025-10-24T13:23Z 1488 followers, XX engagements


"Statins' secret sauce: Aggressive LDL-C guidelines evolved from XXX mg/dL targets in the '80s to XX for high-risk by 2004 (AHA/ACC). Result Usage exploded Sales peaked at $35.3B globally in '09 with Lipitor hitting $13B/yr solo. Awareness + access = goldmine"  
[X Link](https://x.com/doctorvasan/status/1981713281656951000) [@doctorvasan](/creator/x/doctorvasan) 2025-10-24T13:23Z 1488 followers, XX engagements


"Fast-forward to 2025: Guidelines got TOUGHER. ESC/EAS 2025 mandates XX mg/dL for very high-risk (ASCVD) XX for recurrent events. AACE echoes: XX for high-risk but "lower for longer is better"no floor at XX mg/dL. NLA pushes combo therapy for extreme cases (30 mg/dL)"  
[X Link](https://x.com/doctorvasan/status/1981713285914251637) [@doctorvasan](/creator/x/doctorvasan) 2025-10-24T13:24Z 1488 followers, XXX engagements


"@lkatheeq @DKShivakumar @mlanaharis @Captain_Mani72 @Bc_Bengaluru Sir If possible try to move the section between Bellary Rd & OMR a few kilometers to the north (passing just S of Bagalur) as the current alignment passes through density populated areas where buildings have already been constructed like near Bharatiya City Kogilu Cross etc"  
[X Link](https://x.com/doctorvasan/status/1980654288763605191) [@doctorvasan](/creator/x/doctorvasan) 2025-10-21T15:15Z 1486 followers, XXX engagements


"45%. 3) The recent VESUVIUS C trial reinforceslower the better mantra for LDLc that has been gaining ground in Lipidology/Cardiology for several years & guidelines will start reflecting it. Put it all together & the rationale for adding Obi to statin becomes overwhelming"  
[X Link](https://x.com/doctorvasan/status/1981713311394828776) [@doctorvasan](/creator/x/doctorvasan) 2025-10-24T13:24Z 1488 followers, X engagements


"GlobalData: $1.4B in 7MM by '32. Conservative Nahadd Lp(a)/DM/AD labels and it's $5B+ peak easy. EMA MAA validated; US launch late XX. Historical parallel: Lipitor launched '97 into a $1B market; hit $13B peak by '06 on guideline shifts + marketing. Obicetrapib enters a $20B+"  
[X Link](https://x.com/doctorvasan/status/1981713318705246300) [@doctorvasan](/creator/x/doctorvasan) 2025-10-24T13:24Z 1488 followers, XX engagements


"Add in the AD premium that alone is worth $15B+ by 2030. Upside Massive. Sales math: Statins stabilized at $15-17B today (generics crushed prices but volume up). Obicetrapib projections Wells Fargo: $3.5B peak US + $450M EU royalties (Menarini deal)"  
[X Link](https://x.com/doctorvasan/status/1981713314926530654) [@doctorvasan](/creator/x/doctorvasan) 2025-10-24T13:24Z 1488 followers, XX engagements